Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Addiction. 2020 Jan 20;115(5):924–932. doi: 10.1111/add.14886

Figure 1: Extended Kaplan-Meier plots and adjusted hazard ratios* of fatal opioid overdoses, non-fatal opioid overdoses, all-cause mortality, and buprenorphine discontinuation by receipt of benzodiazepines.

Figure 1:

*Adjusted for sex, age, race, Medicaid receipt, diagnosis of depressive disorder, anxiety disorder, bipolar/psychotic disorder, SSRI receipt, time-varying buprenorphine dose, and recent hospital-based mental health encounter (Supplement Table 2 shows full model results).

**Note truncated y-axis for fatal overdose, non-fatal opioid overdose, and all-cause mortality.

***Denotes number of buprenorphine treatment episodes